← Back to Clinical Trials
Recruiting NCT06587321

NCT06587321 Remote Assessment of Signs and Symptoms in Palliative Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06587321
Status Recruiting
Phase
Sponsor Our Lady's Hospice and Care Services
Condition Palliative Care
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-04-01
Primary Completion 2025-03-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-04-01 with a primary completion date of 2025-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Digital health interventions, including remote monitoring of patients, have been identified as a possible way to address current problems within the health service, including insufficient numbers of staff, and an increasing number of patients requiring services. The aim of this study is to assess the feasibility of using remote monitoring for patients who are receiving palliative care and to see whether remote monitoring can improve care and outcomes for patients and their families. Participants in this study will complete regular (daily, weekly, monthly) questionnaires online about how they are feeling. They will also be given equipment to measure their vital signs every day. The clinical team will have access to the results and be able to respond to any new problems as they arise. Patients and their carers will then complete a questionnaire at one month to assess satisfaction with the use of remote monitoring.

Eligibility Criteria

Inclusion Criteria: * Primary diagnosis of advanced cancer or another life-limiting condition * Estimated prognosis greater than 3 months * Referred for community-based specialist palliative care * Living in own home (or home of family carer) * Living with a family carer Exclusion Criteria: * Estimated prognosis less than 3 months or more than 12 months * Cognitive impairment - unable to provide consent / complete assessments * Non-English speaker * Living in care home / nursing home / hospice / community hospital * Not living with a family carer

Contact & Investigator

Central Contact

Gemma O'Keeffe

✉ gokeeffe@olh.ie

📞 01 406 8700

Principal Investigator

Jenny Power

PRINCIPAL INVESTIGATOR

Our Lady's Hospice & Care Services

Frequently Asked Questions

Who can join the NCT06587321 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Palliative Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06587321 currently recruiting?

Yes, NCT06587321 is actively recruiting participants. Contact the research team at gokeeffe@olh.ie for enrollment information.

Where is the NCT06587321 trial being conducted?

This trial is being conducted at Dublin, Ireland.

Who is sponsoring the NCT06587321 clinical trial?

NCT06587321 is sponsored by Our Lady's Hospice and Care Services. The principal investigator is Jenny Power at Our Lady's Hospice & Care Services. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology